Genzyme Corporation (Sanofi) works as the specialty care global business unit of Sanofi that works with focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Every day the unit works to develop new therapies, and innovation to leave a positive impact on the lives of people across the globe.
It was started before more than 30 years, and the company remains just as committed to and passionate about upgrading therapies that offer well facilities to people and caregivers.
The leading company Genzyme Corporation (Sanofi) approaches developing highly specialized treatments and forging close relationships with health care providers and people with health issues.
It was founded as Genzyme in Boston in 1981, that has grown rapidly to become one of the world’s leading biotechnology companies, known for its pioneering development of treatments for rare genetic disorders and the innovative contributions to medical science and biomanufacturing.
The ambition of the growing pharmaceutical company Genzyme Corporation (Sanofi)is to be the industry leader in specialty care. It offers more than 25 treatments to people globally, with various potential new therapies being studied in clinical trials and in Sanofi laboratories.
The commitment of the company is driven by striving to promote strong relationships with its consumers communities, listening to their perspectives. It can truly understand people’s need. It drives the company to guide and motivate their employees.
Genzyme Corporation (Sanofi) is the specialty care global business unit of Sanofi that works with focused in the areas of rare diseases. Visit Genzyme Corporation (Sanofi)!